BridgeBio Pharma, Inc. Ratios

Ratios Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 94.44%95.58%73.71%98.25%
EBT Margin 337,169.23%7,232.16%-711.50%-6,127.87%-1,047.28%-624.72%-7,021.94%-244.34%
EBIT Margin 337,369.23%7,210.84%-656.41%-5,751.99%-1,029.70%-659.65%-6,528.75%-267.22%
EBITDA Margin 337,369.23%7,210.84%-656.41%-5,751.99%-1,029.70%-659.65%-6,528.75%-267.22%
Operating Margin 337,369.23%7,210.84%-656.41%-5,751.99%-1,029.70%-659.65%-6,528.75%-267.22%
Net Margin 235,115.38%5,133.45%-642.47%-5,439.74%-1,004.53%-619.70%-6,913.92%-241.44%
FCF Margin 315,015.38%5,450.37%-631.72%-4,936.74%-912.82%-546.46%-5,686.62%-235.09%
Efficiency
Assets Average 667.63M858.19M817.91M584.71M732.86M
Equity Average 289.99M-380.37M-1055.17M-1298.80M-1411.08M
Invested Capital 548.73M656.26M-867.00M-1243.34M-1354.26M-729.03M
Asset Utilization Ratio 0.010.070.090.020.30
Leverage & Solvency
Interest Coverage Ratio -0.00M-72.11-30.38-12.94-12.33-6.37-7.47-5.97
Debt to Equity 0.190.88-0.50-0.35-0.33-0.50
Debt Ratio 0.150.130.430.690.820.80
Equity Ratio 0.750.15-0.86-2.00-2.48-1.60
Times Interest Earned -0.00M-72.11-30.38-12.94-12.33-6.37-7.47-5.97
Dividends & Payouts
FCF Payout Ratio -0.03-0.32-0.21-0.01
Valuation
Enterprise Value 3,671.99M8,407.95M2,064.20M735.72M6,599.41M4,514.93M
Market Capitalization 4,033.52M8,715.83M2,454.74M1,139.06M7,023.05M5,185.88M
Return Ratios
Return on Sales 72.32%-7.12%-61.28%-10.47%-6.25%-70.22%-2.45%
Return on Capital Employed -0.83%-0.80%-0.74%-1.38%-1.03%
Return on Assets -0.76%-0.68%-0.59%-1.12%-0.74%
Return on Equity -1.74%1.54%0.46%0.50%0.39%